Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinibXinzhao Wang(Shandong Tumor Hospital), Zhiyong Yu(Shandong Tumor Hospital)Oncology ReportsDecember 11, 201410.3892/or.2014.3665Cited by 17SaveCiteExport RISWatch citationsRelated PapersRole of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib|Frontiers in Oncology|2020|153Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer|PLoS ONE|2017|50